Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S. ... | 合法醫療器材資訊網

2019年8月27日—TheAcrySof®IQPanOptix®TrifocalIOLisatypeofmultifocalIOLusedtofocusimagesclearlyontothebackofyoureye(retina)toallowclear ...

Geneva, August 27, 2019 – Alcon (SIX/NYSE:ALC), the global leader in eye care, today announced the Food and Drug Administration (FDA) approval and its initial commercial launch of AcrySof®IQ PanOptix®Trifocal Intraocular Lens (IOL), the first and only trifocal lens for U.S. patients undergoing cataract surgery. PanOptix is clinically shown to deliver an exceptional combination of near, intermediate and distance vision while significantly reducing the need for glasses after surgery.1,2[1]

PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to high-quality distance vision in a range of lighting conditions. The new lens uses ENLIGHTEN®Optical Technology, a proprietary design that optimizes intermediate vision without compromising near and distance vision. Availabl...